Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Aug 11, 2026 · 10-Q · 42 days after period end · 0001193125-26-344624
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$74.77M | -$12.72M | -$8.46M | -$8.24M |
| EPS Diluted | -$0.80 | -$0.37 | -$0.25 | -$0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 11, 2026 · 42 d after period end
